PRKAA1 and acute lymphoblastic leukemia: AMPK activating compounds, such as metformin and 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), were shown to increase GRP78 protein levels in acute lymphoblastic leukemia cell lines, further supporting the molecular interaction between AMPK and GRP78 signaling (64, 65).